The author also thanks all members of the committee on gynecologic oncology of the Japan Society of Obstetrics and Gynecology and Dr Wataru Yamagami in the Department of Obstetrics and Gynecology, School of Medicine, Keio University for their contribution to summarizing the data and Ms Miyuki Nakai and Ms Keiko Abe for their secretarial help. There is no conflict of interest. “
“The Japan Society of Obstetrics and Gynecology collects and analyzes annual data on gynecologic cancers from member institutions. Here we present the Patient Annual Report for 2012 ABT-199 price and the Treatment Annual Report for 2006. Data on 7028 patients with cervical cancer, 8217 with endometrial

cancer, 5140 with ovarian cancer and 1725 with ovarian borderline tumor for whom treatment was initiated in 2012 were summarized in the Patient Annual Report. Data on the prognosis of 2699 patients with cervical cancer, 3243 with endometrial cancer and 1898 with ovarian cancer for whom treatment was initiated in 2006 were analyzed in the Treatment Annual Report. In the Patient Annual Report for 2012, stage I accounted for 55.4%, stage II for 23.0%, stage III for 11.0% and stage Selleckchem KU57788 IV for 10.6% of all patients with cervical cancer. Stage I accounted for 72.2%, stage II for 7.0%, stage III for 13.4% and stage IV for 7.3% of all patients with endometrial cancer. Stage I accounted for 43.1%, stage II for 9.2%, stage III

for 29.7% and stage IV for 7.2% of all patients with ovarian cancer. In the Treatment Annual Report for 2006, the 5-year overall survival rates for patients with cervical cancer were 92.9% for stage I, 74.6% for stage II, 55.3% for stage III and 24.3% for stage IV. The equivalent rates for patients with endometrial cancer were 96.3%, 92.7%, 80.6% and

35.8%, respectively; www.selleck.co.jp/products/MG132.html and those for patients with ovarian surface epithelial–stromal tumors were 90.6%, 82.9%, 48.7% and 40.9%, respectively. “
“Among cases of placental abruption registered in the Perinatal Care Database developed by the Committee on Perinatal Care of the Japan Society of Obstetrics and Gynecology, those in which consent for secondary research was obtained, and the diagnosis of cerebral palsy was established based on the results of examination covered by the obstetrical care payment system, have recently been studied, and the results suggest the following: When placental abruption occurs outside the hospital, it frequently becomes severe, involving intrauterine fetal death and requiring maternal blood transfusion. However, as it is a disease occurring irrespective of the time and location and requiring maternal–fetal emergency care, early delivery is indispensable even when it occurs in hospital. Special attention should be paid to decreased fetal movements or their loss, in addition to abdominal pain and bleeding as initial symptoms.